Skip to main content
. 2021 Apr 10;26(1):293–308. doi: 10.1007/s11030-021-10219-1

Fig. 7.

Fig. 7

(a) Saquayamycin K4 docked to 3CLpro, (b) 2D structure of saquayamycin K4 docked to 3CLpro and (c) the binding mode of the complex of saquayamycin K4 with 3CLpro in the lowest energy structure obtained from MD simulations